Moderna to apply for US & European emergency authorization as Covid-19 vaccine shows 94% efficacy in final analysis ...News

Russia Today - News
Moderna to apply for US & European emergency authorization as Covid-19 vaccine shows 94% efficacy in final analysis
Biotech company Moderna has said it will submit its Covid-19 vaccine candidate for emergency approval in the US and Europe after stage three trials concluded with positive results. In a statement released on Monday, Moderna said that its vaccine has proven to be extremely effective against Covid-19.  According to the firm, final analysis from the trial shows their jab was 94.1 percent effective in stopping Covid-19 infections.  “Today’s primary analysis was based on 196 cases, of which 185 cases of COVID-19 were observed in the placebo group versus 11 cases observed in the mRNA-1273 group, resulting in a point estimate of vaccine effic

Hence then, the article about moderna to apply for us european emergency authorization as covid 19 vaccine shows 94 efficacy in final analysis was published today ( ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Moderna to apply for US & European emergency authorization as Covid-19 vaccine shows 94% efficacy in final analysis )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News